Science-Fiction-to-Science-Fact Diligence
Fund a bold vision in stages, then demand proof at each technical milestone
- Difficulty
- Advanced
- Time to result
- ~months to results
- Steps
- 5
- Confidence
- 97%
The method treats an ambitious startup as a hypothesis rather than a finished investment thesis. The investor first identifies the extraordinary technical claim beneath the founder's story, then risks only enough capital to purchase additional information. Before investing further, the investor defines concrete technological milestones that distinguish a functioning invention from exaggeration, delusion, or fraud. Relevant scientists and engineers examine whether demonstrations use the claimed system under realistic conditions. Capital is then released in stages as evidence accumulates. This preserves exposure to potentially transformative ideas while limiting the damage caused by persuasive narratives that outrun reality. The mechanism is therefore vision followed by falsifiable tests, staged commitment, and evidence-based escalation.
Origin
Josh Wolfe described this approach on Masters in Business while contrasting science-fiction-inspired venture investing with the failure to verify Theranos's scientific claims.
Core principles
- 01Believe in ambitious visions before they become obvious
- 02Treat the initial investment as an option to learn
- 03Separate compelling narratives from working technology
- 04Increase commitment only after objective technical proof
- 05Assume fraud or delusion remains possible until tested
How to run it
- 1
Isolate the technical claim
Translate the founder's narrative into a precise statement about what the technology must accomplish. Separate the inspiring vision from the present scientific capability.
Pro tip Ask what must be true for the company to deserve its proposed valuation.
Watch out A prestigious board or famous backer is not technical evidence.
- 2
Ask whether it works
Demand a direct demonstration or credible experimental record showing that the core technology performs as claimed. Use relevant specialists rather than generalist reputation signals.
Pro tip Test the claimed system under realistic conditions and with independently selected samples.
Watch out Do not let fear of appearing uninformed prevent basic questions.
- 3
Define falsifiable milestones
Specify measurable technical achievements that would confirm or weaken the thesis. Include deadlines, performance thresholds, and conditions for independent verification.
Pro tip Prefer milestones that cannot be satisfied by a staged demo or substituted technology.
Watch out Vague progress reports allow an unsupported narrative to persist.
- 4
Place a limited initial bet
Invest only enough to preserve access and fund the next informative experiment. Treat the commitment as an ante rather than a final verdict.
Pro tip Match the initial check size to the cost of resolving the largest uncertainty.
Watch out A large first commitment can create psychological pressure to defend the company later.
- 5
Escalate with evidence
Increase capital only when the company clears predefined milestones and the evidence survives expert scrutiny. Reassess founder honesty as well as technical performance.
Pro tip Record the original thesis before results arrive so hindsight cannot rewrite it.
Watch out Do not mistake continued fundraising or publicity for technical validation.
In the wild
An investor considering a novel blood-testing platform identifies the minimum accuracy and sample-volume claims that make the business viable. Instead of relying on endorsements, the investor funds a small controlled validation using independently sourced samples and qualified laboratory reviewers. A larger financing is conditional on the platform reproducing its results without hidden conventional equipment.
→ The investor either gains credible evidence before scaling the position or limits losses when the central claim fails.
Common mistakes
Buying the story
A vivid mission, charismatic founder, and famous supporters can create conviction without proving that the underlying technology works.
Using irrelevant prestige
A board filled with distinguished political or military figures cannot replace expertise in the scientific domain being evaluated.
Moving the milestones
Redefining success after each failed experiment prevents the thesis from ever being falsified.
Is it for you?
Best for
It is best for investors evaluating early-stage scientific or engineering ventures with substantial technical uncertainty.
Not ideal for
It is not ideal for mature businesses whose products, economics, and customer demand are already independently observable.
From the transcript
“And you try to find what are the technological milestones that will tell me that this is for real and not BS.”
“And I said, does it work?”
“And you'd be surprised how many people just want to believe the narrative of the story goes back to science fiction and not verifying if…”
From the episode
Josh Wolfe Discusses Innovative Investments (Podcast)
Josh Wolfe